首页> 外文期刊>Intensivmedizin und Notfallmedizin >Kontrastmittel-induzierte Nephropathie
【24h】

Kontrastmittel-induzierte Nephropathie

机译:造影剂诱发的肾病

获取原文
获取原文并翻译 | 示例
       

摘要

The use of iodinated contrast media (CM) continues to be a common cause of hospital-acquired acute renal failure (ARF) and its development increases the in-hospital mortality significantly. Thus, considerable efforts have been made to develop techniques to prevent acute renal failure, or to facilitate its recovery. Various strategies for the prevention of contrast-induced nephropathy (CN) have been studied, with conflicting results. Most studies used hydration as a basic intervention maneuver. Pharmaceutical interventions included the use of antioxidants, adenosine antagonists, sodium bicarbonate, domapine, prostaglandins, etc. Trials with new radio contrast agents (i. e., iodixanol) or gadolinium-containing agents has been limited to a few patients. The results of these trials will be reviewed by this paper, as well as the use of dialysis in order to treat and prevent contrast damage to the kidney.
机译:碘化造影剂(CM)的使用仍然是医院获得性急性肾衰竭(ARF)的常见原因,其发展显着增加了院内死亡率。因此,已经做出了巨大的努力来开发预防急性肾衰竭或促进其恢复的技术。研究了多种预防造影剂肾病(CN)的策略,但结果相矛盾。大多数研究将水合作用作为基本的干预手段。药物干预包括使用抗氧化剂,腺苷拮抗剂,碳酸氢钠,多巴汀,前列腺素等。使用新的放射线造影剂(即碘克沙醇)或含g试剂的试验仅限于少数患者。本文将对这些试验的结果以及使用透析治疗和预防肾脏造影剂损害的情况进行综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号